JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - USD
ISIN LU2050612154 / Valor 50073450
JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - USD
UMushroom community rating:
General Objective
The fund aims to achieve a return by investing in companies with exposure to the theme of genetic therapies on a global scale.
Fund Exposure
The fund is characterized by investing in companies with the highest exposure to the theme of genetic therapies, identified through natural language processing and revenue attribution. The portfolio consists of securities that are not only textually relevant but also of high quality, liquidity, and market capitalization.
Risks
Investors should be aware of the investment risks associated with the fund's techniques and securities, such as concentration, hedging, thematic securities, emerging markets, equities, and smaller companies. Additionally, there are other associated risks related to currency, liquidity, and market factors that could impact the fund's performance. Potential outcomes to shareholders include loss of capital, volatility in share value, and failure to meet the fund's objective.
Source
https://am.jpmorgan.com/lu/en/asset-management/per/products/jpm-thematics-genetic-therapies-c-acc-usd-lu2098775203
Ratings & reviews
OTHER SHARE CLASSES OF THIS FUND
